• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乌干达接受调查的医疗保健专业人员报告的罕见、严重且有全面描述的疑似药物不良反应。

Rare, serious, and comprehensively described suspected adverse drug reactions reported by surveyed healthcare professionals in Uganda.

作者信息

Kiguba Ronald, Karamagi Charles, Waako Paul, Ndagije Helen B, Bird Sheila M

机构信息

Department of Pharmacology and Therapeutics, Makerere University College of Health Sciences, Kampala, Uganda.

Clinical Epidemiology Unit, Makerere University College of Health Sciences, Kampala, Uganda.

出版信息

PLoS One. 2015 Apr 23;10(4):e0123974. doi: 10.1371/journal.pone.0123974. eCollection 2015.

DOI:10.1371/journal.pone.0123974
PMID:25905889
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4408100/
Abstract

BACKGROUND

Lack of adequate detail compromises analysis of reported suspected adverse drug reactions (ADRs). We investigated how comprehensively Ugandan healthcare professionals (HCPs) described their most recent previous-month suspected ADR, and determined the characteristics of HCPs who provided comprehensive ADR descriptions. We also identified rare, serious, and unanticipated suspected ADR descriptions with medication safety-alerting potential.

METHODS

During 2012/13, this survey was conducted in purposively selected Ugandan health facilities (public/private) including the national referral and six regional referral hospitals representative of all regions. District hospitals, health centres II to IV, and private health facilities in the catchment areas of the regional referral hospitals were conveniently selected. Healthcare professionals involved in prescribing, transcribing, dispensing, and administration of medications were approached and invited to self-complete a questionnaire on ADR reporting. Two-thirds of issued questionnaires (1,345/2,000) were returned.

RESULTS

Ninety per cent (241/268) of HCPs who suspected ADRs in the previous month provided information on five higher-level descriptors as follows: body site (206), drug class (203), route of administration (127), patient age (133), and ADR severity (128). Comprehensiveness (explicit provision of at least four higher-level descriptors) was achieved by at least two-fifths (46%, 124/268) of HCPs. Received descriptions were more likely to be comprehensive from HCPs in private health facilities, regions other than central, and those not involved in teaching medical students. Overall, 106 serious and 51 rare previous-month suspected ADRs were described. The commonest serious and rare ADR was Stevens-Johnson syndrome (SJS); mostly associated with oral nevirapine or cotrimoxazole, but haemoptysis after diclofenac analgesia and paralysis after quinine injection were also described.

CONCLUSION

Surveyed Ugandan HCPs who had suspected at least one ADR in the previous month competently provided comprehensive ADR descriptions: more, indeed, than are received per annum nationally. Properly analyzed, and with local feed-back, voluntary ADR reports by HCPs could be an essential alerting tool for identifying rare and serious suspected ADRs in Uganda.

摘要

背景

缺乏足够的细节会影响对报告的疑似药物不良反应(ADR)的分析。我们调查了乌干达医疗保健专业人员(HCP)对其上个月最近一次疑似ADR的描述有多全面,并确定了提供全面ADR描述的HCP的特征。我们还识别了具有药物安全警示潜力的罕见、严重和意外的疑似ADR描述。

方法

在2012/13年期间,这项调查在有目的地选择的乌干达医疗机构(公立/私立)中进行,包括国家转诊医院和代表所有地区的六家区域转诊医院。方便地选择了地区医院、二级至四级卫生中心以及区域转诊医院集水区内的私立医疗机构。与药物处方、转录、配药和给药相关的医疗保健专业人员被联系并被邀请自行填写一份关于ADR报告的问卷。发放的问卷中有三分之二(1345/2000)被收回。

结果

上个月怀疑有ADR的HCP中有90%(241/268)提供了关于五个更高层次描述符的信息,如下所示:身体部位(206)、药物类别(203)、给药途径(127)、患者年龄(133)和ADR严重程度(128)。至少五分之二(46%,124/268)的HCP实现了全面性(明确提供至少四个更高层次的描述符)。私立医疗机构、中部以外地区以及不参与医学生教学的HCP提供的描述更有可能是全面的。总体而言,描述了106例严重和51例罕见的上个月疑似ADR。最常见的严重和罕见ADR是史蒂文斯-约翰逊综合征(SJS);主要与口服奈韦拉平或复方新诺明有关,但也描述了双氯芬酸镇痛后咯血和奎宁注射后麻痹。

结论

接受调查的上个月至少怀疑有一例ADR的乌干达HCP能够提供全面的ADR描述:实际上,比全国每年收到的描述还要多。经过适当分析并给予当地反馈,HCP的自愿ADR报告可能是识别乌干达罕见和严重疑似ADR的重要警示工具。

相似文献

1
Rare, serious, and comprehensively described suspected adverse drug reactions reported by surveyed healthcare professionals in Uganda.乌干达接受调查的医疗保健专业人员报告的罕见、严重且有全面描述的疑似药物不良反应。
PLoS One. 2015 Apr 23;10(4):e0123974. doi: 10.1371/journal.pone.0123974. eCollection 2015.
2
Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants.乌干达接受调查的医疗保健专业人员对疑似药物不良反应的识别与报告:关键决定因素
BMJ Open. 2014 Nov 24;4(11):e005869. doi: 10.1136/bmjopen-2014-005869.
3
Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.评估患者向英国“黄卡计划”报告药物不良反应的情况:文献回顾、描述性和定性分析以及问卷调查。
Health Technol Assess. 2011 May;15(20):1-234, iii-iv. doi: 10.3310/hta15200.
4
Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda.撒哈拉以南非洲地区医疗保健专业人员的用药错误披露及报告态度:乌干达的一项调查
Drugs Real World Outcomes. 2015 Sep 1;2(3):273-287. doi: 10.1007/s40801-015-0032-7.
5
Awareness, knowledge, and attitude toward adverse drug reaction (ADR) reporting among healthcare professionals in Ghana.加纳医疗保健专业人员对药品不良反应(ADR)报告的认知、知识和态度。
Ther Adv Drug Saf. 2022 Aug 6;13:20420986221116468. doi: 10.1177/20420986221116468. eCollection 2022.
6
Adverse drug reaction reporting among health care workers at Mulago National Referral and Teaching hospital in Uganda.乌干达穆拉戈国家转诊与教学医院医护人员的药品不良反应报告
Afr Health Sci. 2015 Dec;15(4):1308-17. doi: 10.4314/ahs.v15i4.34.
7
Knowledge of Adverse Drug Reaction Reporting Among Healthcare Professionals in Bhutan: A Cross-Sectional Survey.不丹医疗保健专业人员的药品不良反应报告知识:一项横断面调查
Drug Saf. 2016 Dec;39(12):1239-1250. doi: 10.1007/s40264-016-0465-2.
8
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.法国首次报告大流行流感疫苗(H1N1)接种后患者不良反应:患者和医务人员报告的比较。
Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.1007/BF03261980.
9
Improving adverse drug event reporting by healthcare professionals.提高医疗保健专业人员对药物不良事件的报告率。
Cochrane Database Syst Rev. 2024 Oct 29;10(10):CD012594. doi: 10.1002/14651858.CD012594.pub2.
10
Barriers to and facilitators of healthcare professionals in ADR reporting in a tertiary care hospital in India.印度一家三级医院中医疗保健专业人员进行药品不良反应报告的障碍与促进因素
BMC Health Serv Res. 2025 Jan 28;25(1):166. doi: 10.1186/s12913-024-12139-w.

引用本文的文献

1
Adverse Drug Reaction Onsets in Uganda's VigiBase: Delayed International Visibility, Data Quality and Illustrative Signal Detection Analyses.乌干达药物不良反应监测数据库中的药物不良反应发生情况:国际上的延迟可见性、数据质量及典型信号检测分析
Pharmaceut Med. 2018;32(6):413-427. doi: 10.1007/s40290-018-0253-7. Epub 2018 Nov 17.
2
Antibiotic-associated suspected adverse drug reactions among hospitalized patients in Uganda: a prospective cohort study.乌干达住院患者中与抗生素相关的疑似药物不良反应:一项前瞻性队列研究。
Pharmacol Res Perspect. 2017 Feb 17;5(2):e00298. doi: 10.1002/prp2.298. eCollection 2017 Apr.
3
Incidence, risk factors and risk prediction of hospital-acquired suspected adverse drug reactions: a prospective cohort of Ugandan inpatients.医院获得性疑似药物不良反应的发生率、危险因素及风险预测:乌干达住院患者的前瞻性队列研究
BMJ Open. 2017 Jan 20;7(1):e010568. doi: 10.1136/bmjopen-2015-010568.
4
Medication Error Disclosure and Attitudes to Reporting by Healthcare Professionals in a Sub-Saharan African Setting: A Survey in Uganda.撒哈拉以南非洲地区医疗保健专业人员的用药错误披露及报告态度:乌干达的一项调查
Drugs Real World Outcomes. 2015 Sep 1;2(3):273-287. doi: 10.1007/s40801-015-0032-7.

本文引用的文献

1
Recognition and reporting of suspected adverse drug reactions by surveyed healthcare professionals in Uganda: key determinants.乌干达接受调查的医疗保健专业人员对疑似药物不良反应的识别与报告:关键决定因素
BMJ Open. 2014 Nov 24;4(11):e005869. doi: 10.1136/bmjopen-2014-005869.
2
Hemoptysis and pulmonary edema in a scuba diver using diclofenac.潜水员使用双氯芬酸后出现咯血和肺水肿。
Pharmacology. 2012;89(1-2):103-4. doi: 10.1159/000336059. Epub 2012 Feb 21.
3
Drug-induced Stevens-Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), and SJS-TEN overlap: a multicentric retrospective study.药物性史蒂文斯-约翰逊综合征(SJS)、中毒性表皮坏死松解症(TEN)及SJS-TEN重叠综合征:一项多中心回顾性研究
J Postgrad Med. 2011 Apr-Jun;57(2):115-9. doi: 10.4103/0022-3859.81865.
4
Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda.乌干达一家区级和地区级医院内科病房收治患者的药物不良反应
Afr Health Sci. 2011 Mar;11(1):72-8.
5
Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration.态度对药师向食品药品监督管理局报告严重药物不良事件意愿的影响。
Br J Clin Pharmacol. 2011 Jul;72(1):143-52. doi: 10.1111/j.1365-2125.2011.03944.x.
6
Hemoptysis under diclofenac and antiplatelet doses of aspirin.双氯芬酸和阿司匹林抗血小板剂量下的咯血。
Pharmacology. 2011;87(1-2):1-4. doi: 10.1159/000321728. Epub 2010 Dec 8.
7
Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.住院患者的药物不良反应:对3695例患者诊疗过程的前瞻性分析
PLoS One. 2009;4(2):e4439. doi: 10.1371/journal.pone.0004439. Epub 2009 Feb 11.
8
Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study.三级转诊中心急诊科不良药物反应的患病率及经济负担评估:一项前瞻性研究。
BMC Clin Pharmacol. 2007 Jul 28;7:8. doi: 10.1186/1472-6904-7-8.
9
Pharmacovigilance of antimalarial treatment in Africa: is it possible?非洲抗疟治疗的药物警戒:是否可行?
Malar J. 2006 Jun 16;5:50. doi: 10.1186/1475-2875-5-50.
10
Under-reporting of adverse drug reactions : a systematic review.药品不良反应报告不足:一项系统评价
Drug Saf. 2006;29(5):385-96. doi: 10.2165/00002018-200629050-00003.